ESC Premium Access

Can we avoid randomized clinical trials for new CV drugs? .

Congress Presentation

About the speaker

Ms Karen Pieper

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

3 more presentations in this session

Critical issues in endpoint definition.

Speaker: Professor J. Tijssen (Amsterdam, NL)


Lost to follow-up in cardiovascular trials.

Speaker: Associate Professor V. Serebruany (Baltimore, US)


Current controversies in clinical trial design - Panel discussion.


Access the full session

Current controversies in clinical trial design

Speakers: Ms K. Pieper, Professor J. Tijssen, Associate Professor V. Serebruany

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb